Ads blast Merck on AIDS drug prices in Mexico

Share this article:
Ads blast Merck on AIDS drug prices in Mexico
Ads blast Merck on AIDS drug prices in Mexico
The AIDS Healthcare Foundation launched a print ad aimed at shaming Merck in its own neighborhood for the prices it charges for AIDS drug Stocrin (Sustiva) in Mexico.

The nonprofit, a frequent nemesis of the pharma industry which has previously run ads slamming drug companies for how they price and market their drugs, ran the ad in The Courier News of Somerset County, NJ, near Merck's US corporate headquarters. With the tagline “Shame on Merck,” the ad copy reads in part: “Merck's Stocrin (efavirenz) is the backbone of many standard antiretroviral drug regimens. AIDS advocates question why Stocrin costs approximately $140 USD in Honduras, yet Merck charges $893 USD for Stocrin in Mexico. Advocates and HIV/AIDS patients insist Merck must match its lowest available price of Stocrin in other Latin American countries in Mexico as well.”

The ads, timed to coincide with the 2008 International AIDS conference in Mexico, will also appear in The Hunterdon County Democrat, The Village Voice and The Washington Blade.
Share this article:

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.